Physician profile
Sharon A Wright
NPI 1407174279
$1,282.81
in general payments reported to CMS, 2019-2025
14 companies · $452 in 2025
The $452 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $107 · 2023: $338 · 2024: $386 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,175.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $613.39 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $135.77 | 2024-2025 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $112.55 | 2023-2024 | Caplyta |
| Janssen Pharmaceuticals, INC | $106.99 | 2021 | |
| Astellas Pharma US INC | $92.70 | 2023 | Veozah |
| Exact Sciences Corporation | $40.16 | 2023-2024 | Cologuard Collection Kit |
| Amgen INC. | $38.24 | 2023-2024 | Repatha, Otezla, Evenity |
| Pfizer INC. | $28.40 | 2024 | |
| Novo Nordisk INC | $25.21 | 2025 | Rybelsus, Ozempic |
| Lexicon Pharmaceuticals, INC. | $20.02 | 2023 | Inpefa |
| Bayer Healthcare Pharmaceuticals INC. | $18.63 | 2024 | |
| Lilly USA, LLC | $18.53 | 2025 | Zepbound |
| Viatris Specialty LLC | $18.25 | 2025 | Yupelri |
| Galderma Laboratories, L.P. | $13.97 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.